Literature DB >> 34675592

Clinical Value of C-Reactive Protein/Platelet Ratio in Neonatal Sepsis: A Cross-Sectional Study.

Xiaojuan Li1, Tiewei Li1, Jingjing Wang2, Yichuan Feng1, Chong Ren1, Zhe Xu1, Junmei Yang1, Qian Zhang3, Caiyan An4.   

Abstract

PURPOSE: C-reactive protein (CRP) level and platelet (PLT) count have been demonstrated to be independent risk factor for neonatal sepsis. However, no data is currently available in regarding the association between CRP-to-PLT ratio (CPR) and neonatal sepsis.
METHODS: A total of 1048 neonates with suspected sepsis were enrolled in this study. Complete clinical and laboratory data were collected. CPR was calculated as CRP (mg/L)/PLT (107 cells/L). Multivariate logistic regression analysis was performed to identify the potential independent risk factors of neonatal sepsis. Receiver operating characteristic (ROC) curve analysis was used to evaluate the prediction accuracy of CPR in predicting neonatal sepsis.
RESULTS: Neonates with sepsis had a higher CPR. CPR also showed a gradual increase in the infection, mild sepsis and severe sepsis groups. Multivariate analysis revealed that CPR was a significant independent predictor of the presence of neonatal sepsis (odds ratio [OR], 1.015; 95% confidence interval [CI], 1.008-1.022, P < 0.001) and severe sepsis (OR, 1.002; 95% CI, 1.000-1.003, P = 0.007). ROC curve revealed showed that CPR had a well-discriminatory power in predicting sepsis (area under curve [AUC], 0.68; 95% CI, 0.65-0.72, P < 0.001) and severe sepsis (AUC, 0.68; 95% CI, 0.65-0.72, P < 0.001).
CONCLUSION: The present study demonstrated that a higher CPR is an independent predictor of the presence and severity of neonatal sepsis.
© 2021 Li et al.

Entities:  

Keywords:  C-reactive protein-to-platelet ratio; neonatal sepsis; risk factor; severe sepsis

Year:  2021        PMID: 34675592      PMCID: PMC8502539          DOI: 10.2147/JIR.S334642

Source DB:  PubMed          Journal:  J Inflamm Res        ISSN: 1178-7031


Instruction

Neonatal sepsis remains a serious and life-threatening disease in infants worldwide, despite the improvements in neonatology. Previously published data revealed that neonatal sepsis constituted 15.2% of deaths in the neonatal period worldwide,1 and is a major cause of infant mortality.2,3 The gold-standard for diagnosis of neonatal sepsis is blood culture. However, blood culture poses several challenges, such as a long laboratory turnaround time, an inadequate volume of blood and pre-hospital antimicrobial therapy.4,5 In addition, the clinical signs of neonatal sepsis are multiple and non-specific, including bradycardia, temperature instability, diminished spontaneous activity and respiratory distress.6 Therefore, identifying rapid, sensitive, and specific new biomarkers is critical. C-reactive protein (CRP) is an acute-phase protein produced by the liver and closely associated with systemic inflammatory status.7 In 1988, Povoa et al8 reported for the first time that CRP was an indicator of sepsis. Subsequently, multiple studies confirmed that CRP was an important predictor and risk factor for sepsis.9,10 CRP evaluation was also one of the most investigated and used laboratory tests for diagnosing neonatal sepsis, and higher CRP levels were associated with an increased risk of sepsis.11 However, CRP was not efficiently validated as a screening biomarker.12 Platelets (PLTs) are circulating blood cells, which play an important role in haemostasis and coagulation. PLTs can release inflammatory cytokines, interact with endothelial cells and contribute to the formation of a microthrombus, eventually leading to multiple organ failure.13 Studies have demonstrated that PLTs are involved in the pathogenesis of sepsis and contribute to its complications.14,15 Clinical studies have reported that patients with severe sepsis have a lower PLT count,16 which is associated with enhanced mortality and a more disturbed host response.17 The CRP-to-PLT ratio (CPR), based on CRP levels and PLT counts, indicates not only the inflammation but also the coagulation status. However, no data is currently available regarding the association of CPR with the neonatal sepsis. Therefore, this study aimed to assess the relationship between CPR and neonatal sepsis.

Materials and Methods

Study Design and Patient Population

From January 2016 to February 2020, a total 1098 consecutive neonates with suspected sepsis in Henan Children’s Hospital (Zhengzhou, China) were enrolled in this study. The inclusion criteria were described as follows: (1) neonates with suspected sepsis and (2) neonates aged 1–28 days. Neonates with the following conditions were excluded from this study: (1) with haematological system diseases, malignancies or major congenital malformations and (2) incomplete clinical and laboratory data at admission. The study protocol complied with the Declaration of Helsinki and was approved by the ethics review board of the hospital. Informed consent was not required because the data were anonymised.

Clinical Definition

According to the recommendations of the International Pediatric Sepsis Consensus,18 neonatal sepsis is defined as suspected or proven infection accompanied by≥ 2 systemic inflammatory response syndrome (SIRS) criteria, one being an abnormal body temperature or leukocyte count. The criteria for SIRS are as follows: (1) body temperature > 38.5°C or < 36°C; (2) mean heart rate > 2 SD above normal for age in the absence of external stimuli or unexplained persistent elevation in children aged < 1 year old or mean heart rate < 10th percentile for age, or unexplained persistent depression over a 0.5hr; (3) mean respiratory rate of > 2 SD above normal for age or in the presence of mechanical ventilation; and (4) abnormal leukocyte count or >10% immature neutrophils. Severe sepsis is defined as sepsis accompanied by one of the following: cardiovascular organ dysfunction or acute respiratory distress syndrome or ≥ 2 organ dysfunctions. Detailed information can be obtained from the International Pediatric Sepsis Consensus.18

Data Collection and Biochemical Analyses

All clinical and laboratory data were obtained from medical records, including age; gender; weight; temperature; respiratory rate; heart rate; systolic blood pressure; diastolic blood pressure and the levels of procalcitonin (PCT), CRP, white blood cells (WBCs), neutrophils, PLTs, aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine (CREA) and uric acid (UA). The detection methods of these laboratory indices are described in our previous published study.19 CRP level < 0.8 mg/L or PCT level > 100 ng/mL or < 0.02 ng/mL were considered as 0.7 mg/L, 101 ng/mL and 0.01 ng/mL, respectively. CPR was calculated as CRP/PLT *103.

Statistical Analysis

Continuous data were expressed as the mean ± standard deviation (SD) or medians (interquartile range) and analysed using independent Student’s t-tests, one-way analysis of variance (ANOVA) or Mann–Whitney U-test, according to their distribution. Categorical variables were presented as percentages (n, %) and analysed using the chi-square or Fisher exact tests. The Pearson or Spearman correlation analysis was performed to determine the correlation between two continuous variables. Univariate and multivariate logistic regression analyses were performed to evaluate whether CPR was an independent risk factor for the presence and severity of neonatal sepsis. Variables with a P value < 0.05 in the univariate logistic analysis were included in the multiple regression analysis. The prediction accuracy was evaluated using the area under the receiver operating characteristic (ROC) curves. All statistical analyses were performed using SPSS 22.0 (SPSS Inc., Chicago, Illinois, USA). A two-sided P value < 0.05 was considered statistically significant.

Results

Patient Characteristics

A total of 1098 neonates with suspected sepsis who met the inclusion criteria were enrolled in this study. Of the 1098 neonates, 599 were clinically diagnosed with sepsis; of which, 256 and 343 were diagnosed with mild sepsis and severe sepsis, respectively. The remaining 449 neonates without sepsis were classified as the infection group. Clinical characteristics and laboratory data of patients are provided in Table 1. Compared with neonates in the infection group, neonates with sepsis were older; had higher body temperature, respiratory rate and heart rate; and had higher levels of PCT, CRP, neutrophils, ALT, BUN, UA and CPR (P < 0.001). However, the levels of PLT and CREA were significantly decreased (P < 0.05) in neonates with sepsis. Based on the severity of sepsis, the neonates were divided into the following two groups: mild sepsis group and severe sepsis group. Further analysis showed that only PCT levels, CRP levels and CPR showed a significant gradual increase in the infection, mild sepsis and severe sepsis groups (P < 0.05).
Table 1

Basic Characteristics of Study Subjects

VariablesInfection (n = 449)Sepsis (n = 599)Sepsis
Mild Sepsis (n = 256)Severe Sepsis (n = 343)
Age (days)7.0 (4.0, 12.0)11.0 (6.0, 17.0)a11.0 (6.0, 18.0)c10.0 (6.0, 16.0)d
Male, n (%)262 (58.4%)375 (62.6%)165 (64.5%)210 (61.2%)
Weight (kg)3.3 ± 0.53.2 ± 0.6a3.3 ± 0.63.1 ± 0.7bd
Temperature (°C)37.0 ± 0.537.3 ± 0.8a37.4 ± 0.7c37.3 ± 0.8d
Respiratory (rate/minute)46.5 ± 7.649.7 ± 10.1a49.4 ± 9.6c50.0 ± 10.4d
Heart rate (bpm)142.7 ± 16.1150.3 ± 18.0a149.6 ± 17.7c150.8 ± 18.3d
SBP (mm Hg)76.4 ± 7.176.3 ± 8.079.3 ± 5.6c74.1 ± 9.0bd
DBP (mm Hg)46.6 ± 7.346.2 ± 7.847.7 ± 7.645.0 ± 7.7bd
Laboratory tests
 PCT (ng/mL)0.14 (0.09, 0.22)0.28 (0.13, 1.23)a0.22 (0.11, 0.66)c0.36 (0.65, 1.88)bd
 CRP (mg/L)0.7 (0.7, 0.7)0.7 (0.7, 12.8)a0.7 (0.7, 8.1)c0.7 (0.7, 17.5)bd
 WBC (109 cells/L)10.0 (8.1, 12.2)10.0 (7.3, 13.9)9.4 (7.4, 12.6)10.7 (7.0, 15.8)bd
 Neutrophils (109 cells/L)4.18 (3.13, 5.82)4.89 (3.02, 8.33)a4.47 (3.01, 6.95)5.52 (3.05, 9.37)bd
 PLT (109 cells/L)293.0 (229.5, 365.0)266.0 (170, 364.0)a297.0 (216.2, 368.7)237.0 (121.0, 359.0)bd
 CPR (mg/106 cells)2.49 (1.95, 3.56)4.81 (2.28, 57.05)c3.10 (2.15, 26.06)c8.97 (2.63, 96.60) bd
 AST (U/L)37.5 (30.0, 49.9)37.8 (27.9, 52.7)36.2 (27.9, 47.9)38.9 (27.8, 58.5)b
 ALT (U/L)25.1 (20.0, 33.4)28.6 (22.1, 37.9)a28.7 (22.7, 36.2)c28.5 (22.0, 39.6)d
 BUN (mM)2.2 (1.4, 3.3)3.0 (1.9, 4.2)a2.8 (1.8, 3.9)c3.2 (1.9, 4.7)bd
 CREA (μM)50.0 (41.3, 57.6)45.2 (35.9, 60.3)a43.3 (34.7, 53.2)c47.7 (37.2, 64.3)b
 UA (μM)137.5 (103.0, 178.9)143.0 (106.5, 195.6)a140.7 (106.7, 182.9)143.8 (105.4, 207.0)d

Notes: All values are presented as the mean ± SD or n (%) or as the median (interquartile range); aP < 0.05 for sepsis vs control; bP < 0.05 for severe sepsis vs mild sepsis; cP < 0.05 for mild sepsis vs control; dP < 0.05 for severe sepsis vs control.

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; PCT, procalcitonin; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; CREA, creatinine; UA, uric acid; CPR, C-reactive protein-to-platelet ratio.

Basic Characteristics of Study Subjects Notes: All values are presented as the mean ± SD or n (%) or as the median (interquartile range); aP < 0.05 for sepsis vs control; bP < 0.05 for severe sepsis vs mild sepsis; cP < 0.05 for mild sepsis vs control; dP < 0.05 for severe sepsis vs control. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; PCT, procalcitonin; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; CREA, creatinine; UA, uric acid; CPR, C-reactive protein-to-platelet ratio.

Association of CPR with Neonatal Sepsis

According to the CPR tertiles, we classified the neonates into three groups. As shown in Table 2, neonates in tertile 3 had higher level of PCT levels and neutrophils counts. The prevalence of sepsis increased significantly from 44.6% in tertile 1 to 81.7% in tertile 3 (P < 0.001), whereas the infection group was more likely to be in CPR tertile 1 and tertile 2. Further analysis revealed that the prevalence of severe sepsis was significantly higher in CPR tertile 3 than that in tertile 1 and tertile 2 (P < 0.05).
Table 2

The Presence and Severity of Neonatal Sepsis Based on CPR Tertiles

VariablesTertile 1 (< 2.33) (n = 350)Tertile 2 (2.33–5.52) (n = 349)Tertile 3 (> 5.52) (n = 349)
Age (days)11.0 (7.0, 16.0)6.0 (4.0, 13.0)a9.0 (5.0, 16.0)bc
Male, n (%)187 (53.4%)226 (64.8%)a224 (64.2%)b
PCT (ng/mL)0.12 (0.09, 0.18)0.17 (0.11, 0.35)a0.50 (0.19, 2.92)bc
WBC (109 cells/L)10.7 (8.9, 13.5)8.9 (7.0, 11.6)a10.1 (6.8, 14.2)bc
Neutrophils (109 cells/L)4.3 (3.3, 6.3)4.3 (2.8, 6.3)5.0 (3.1, 9.1)bc
Clinical data
 Infection, n (%)194 (55.4%)191 (54,7%)64 (18.3%)bc
 Overall sepsis, n (%)156 (44.6%)158 (45.3%)285 (81.7%)bc
 Mild sepsis, n (%)81 (23.1%)79 (22.6%)96 (27.5%)
 Severe sepsis, n (%)75 (21.4%)79 (22.6%)189 (54.2%)bc

Notes: aP < 0.05 for Tertile 2 vs Tertile 1; bP < 0.05 for Tertile 3 vs Tertile 1; cP < 0.05 for Tertile 3 vs Tertile 2.

Abbreviations: abbreviations as in Table 1.

The Presence and Severity of Neonatal Sepsis Based on CPR Tertiles Notes: aP < 0.05 for Tertile 2 vs Tertile 1; bP < 0.05 for Tertile 3 vs Tertile 1; cP < 0.05 for Tertile 3 vs Tertile 2. Abbreviations: abbreviations as in Table 1.

Predictive Value of CPR for Neonatal Sepsis

Univariate and multivariable binary logistic regression analyses were performed to evaluate the role of CPR in the diagnosis of neonatal sepsis (Table 3). After adjusting age; temperature; heart rate; respiratory rate; weight; neutrophil counts and the levels of PCT, ALB, ALP, AST, ALT, UREA and UA, CPR was proved to be an independent predictor of neonatal sepsis (odds ratio [OR], 1.015, 95% confidence interval [CI], 1.008–1.022, P < 0.001). Furthermore, our data also revealed that the tertiles of CPR were independently associated with an increased prevalence of neonatal sepsis. In addition, our data also confirmed that CPR and CPR tertiles were independent predictor of severe sepsis.
Table 3

Regression Analysis to Assess the Presence of Neonatal Sepsis and Severe Sepsis Based on CPR Tertiles

VariablesUnivariateMultivariate*
OR (95% CI)POR (95% CI)P
Presence of sepsis
 CPR1.024 (1.017–1.032)< 0.0011.015 (1.008–1.022)< 0.001
 CPR tertiles
 Tertile 111
 Tertile 21.029 (0.764–1.386)0.8520.908 (0.628–1.313)0.628
 Tertile 35.538 (3.928–7.807)< 0.0012.331 (1.527–3.559)< 0.001
Presence of severe sepsis
 CPR1.004 (1.003–1.006)< 0.0011.002 (1.000–1.003)0.007
 CPR tertiles
 Tertile 111
 Tertile 21.073 (0.750–1.534)0.7000.929 (0.623–1.385)0.717
 Tertile 34.331 (3.111–6.030)< 0.0011.918 (1.291–2.850)0.001

Notes: *Adjusted for age, temperature, heart rate, respiratory rate, weight, PCT, Neutrophil, ALB, ALP, AST, ALT, UREA and UA.

Abbreviations: abbreviations as in Table 1.

Regression Analysis to Assess the Presence of Neonatal Sepsis and Severe Sepsis Based on CPR Tertiles Notes: *Adjusted for age, temperature, heart rate, respiratory rate, weight, PCT, Neutrophil, ALB, ALP, AST, ALT, UREA and UA. Abbreviations: abbreviations as in Table 1.

Diagnostic Performance of the CPR

ROC curve analysis was performed to evaluate the predictive value of CPR for sepsis. As shown in Figure 1A, the area under the ROC curves (AUC) showed a well discriminatory power of CPR (AUC = 0.68, 95% CI, 0.65–0.72, P < 0.001) in predicting neonatal sepsis. The optimal diagnostic cut-off point was 5.41 mg/106 cells, with 49% sensitivity and 86% specificity. In addition, we also analyzed the role of CPR in predicting severe sepsis. The AUC value for CPR in predicting severe sepsis was 0.68 (95% CI, 0.64–0.72, P < 0.001) (Figure 1B). The optimal diagnostic cut-off point was 6.10 mg/106 cells (with a sensitivity of 55% and specificity of 78%).
Figure 1

ROC curve of CPR in predicting sepsis and severe sepsis in neonates. (A) The ROC curve for CPR in predicting sepsis. (B) The ROC curve for CPR in predicting severe sepsis.

ROC curve of CPR in predicting sepsis and severe sepsis in neonates. (A) The ROC curve for CPR in predicting sepsis. (B) The ROC curve for CPR in predicting severe sepsis.

Discussion

Neonatal sepsis is a serious life-threatening disease. Although the current diagnosis and treatment technologies have made significant progress, the diagnosis of neonatal sepsis still faces many challenges. For example, blood culture, the gold standard for diagnosis of neonatal sepsis, has a long laboratory turnaround time, which may cause a delay in diagnosis and the effective treatment.20 In addition, owing to the use of antibiotics before hospitalisation and an inadequate volume of blood, blood culture yields a low positive rate.20 Moreover, the clinical signs of neonatal sepsis are multiple and non-specific.6 Therefore, circulating blood biomarkers that may be useful in the early diagnosis of neonatal sepsis are under investigation.21 Sepsis is characterized by SIRS caused by pathogens infection, and biomarkers of inflammation play an important role in the diagnosis of neonatal sepsis.22,23 CRP is a well-known and commonly used marker, which was closely associated with inflammation-related diseases.7 Various studies have demonstrated the CRP is an important prognostic factor for neonatal sepsis.24–27 However, CRP exhibited a low specificity owing to its physiological increase after birth or the presence of non-infection-related conditions.11,28 PLTs are anucleate cells that play an important role in modulating haemostasis and developing thrombosis.29,30 Increasing evidences has revealed that PLTs played a critical role in inflammation and immune responses.31,32 PLTs can interacts with other leukocytes by expressing and secreting adhesion molecules and immune modulators, which further enhances inflammation.33–36 In addition to the hyperinflammation caused by PLTs, they can also catalyse the development of disseminated intravascular coagulation and microthrombosis, leading to sepsis complications and organ dysfunction.13 Clinical studies have demonstrated that a low PLT count is a well-known biomarker for disease severity of sepsis33,37 and an independent prognostic predictor of 1-year overall survival of patients with sepsis.38 CPR, as an emerging risk factor, can reflect both inflammation and coagulation status. However, there are no published studies regarding the relationship between CPR and neonatal sepsis. In this study, for the first time, we investigated the predictive role of CPR in neonatal sepsis based on a relatively large sample size. Our data revealed that the level of CPR was higher in neonates with sepsis and increased with the disease severity of sepsis. The neonates were divided into three groups based on the CPR tertiles. Further analysis revealed that the prevalence of sepsis was significantly higher in CPR tertile 3 (up to 81.7%), than in CPR tertile 1 and tertile 2. Multivariate analysis revealed that the CPR was an independent predictor of the presence and severity of neonatal sepsis. The ROC curve analysis revealed that the CPR had a well discriminatory power in predicting sepsis and severe sepsis. Limitations to the study include the fact that this is a retrospective single-center study, which may lead to some information and selection biases. Second, the diagnosis of neonatal sepsis was based on clinical features and was not confirmed by positive blood culture. Therefore, the incidence rate of sepsis may be underestimated or overestimated. Third, CPR was only measured at admission; serial CPR evaluation may be useful to further explore the dynamic correlation between CPR and neonatal sepsis. Lastly, all of the enrolled patients were neonates with suspected sepsis. Therefore, the findings of this study may not be applicable to other populations.

Conclusions

In conclusion, our study demonstrated that CPR was higher in neonates with sepsis and increased with the disease severity. After adjusting for other variables, CPR was independently associated with the presence and severity of neonatal sepsis. Our findings highlight the potential clinical value of CPR in predicting the risk of neonatal sepsis.
  38 in total

Review 1.  Platelets and the immune continuum.

Authors:  John W Semple; Joseph E Italiano; John Freedman
Journal:  Nat Rev Immunol       Date:  2011-04       Impact factor: 53.106

Review 2.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

Review 3.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

4.  C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study.

Authors:  Martin Stocker; Wendy van Herk; Salhab El Helou; Sourabh Dutta; Frank A B A Schuerman; Rita K van den Tooren-de Groot; Jantien W Wieringa; Jan Janota; Laura H van der Meer-Kappelle; Rob Moonen; Sintha D Sie; Esther de Vries; Albertine E Donker; Urs Zimmerman; Luregn J Schlapbach; Amerik C de Mol; Angelique Hoffman-Haringsma; Madan Roy; Maren Tomaske; René F Kornelisse; Juliette van Gijsel; Eline G Visser; Frans B Plötz; Paul Heath; Niek B Achten; Dirk Lehnick; Annemarie M C van Rossum
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

5.  Platelet and leukocyte activation correlate with the severity of septic organ dysfunction.

Authors:  Stefan Russwurm; James Vickers; Andreas Meier-Hellmann; Peter Spangenberg; Don Bredle; Konrad Reinhart; Wolfgang Lösche
Journal:  Shock       Date:  2002-04       Impact factor: 3.454

6.  Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients.

Authors:  Theodora A M Claushuis; Lonneke A van Vught; Brendon P Scicluna; Maryse A Wiewel; Peter M C Klein Klouwenberg; Arie J Hoogendijk; David S Y Ong; Olaf L Cremer; Janneke Horn; Marek Franitza; Mohammad R Toliat; Peter Nürnberg; Aeilko H Zwinderman; Marc J Bonten; Marcus J Schultz; Tom van der Poll
Journal:  Blood       Date:  2016-03-08       Impact factor: 22.113

7.  Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Haidong Wang; Chelsea A Liddell; Matthew M Coates; Meghan D Mooney; Carly E Levitz; Austin E Schumacher; Henry Apfel; Marissa Iannarone; Bryan Phillips; Katherine T Lofgren; Logan Sandar; Rob E Dorrington; Ivo Rakovac; Troy A Jacobs; Xiaofeng Liang; Maigeng Zhou; Jun Zhu; Gonghuan Yang; Yanping Wang; Shiwei Liu; Yichong Li; Ayse Abbasoglu Ozgoren; Semaw Ferede Abera; Ibrahim Abubakar; Tom Achoki; Ademola Adelekan; Zanfina Ademi; Zewdie Aderaw Alemu; Peter J Allen; Mohammad AbdulAziz AlMazroa; Elena Alvarez; Adansi A Amankwaa; Azmeraw T Amare; Walid Ammar; Palwasha Anwari; Solveig Argeseanu Cunningham; Majed Masoud Asad; Reza Assadi; Amitava Banerjee; Sanjay Basu; Neeraj Bedi; Tolesa Bekele; Michelle L Bell; Zulfiqar Bhutta; Jed D Blore; Berrak Bora Basara; Soufiane Boufous; Nicholas Breitborde; Nigel G Bruce; Linh Ngoc Bui; Jonathan R Carapetis; Rosario Cárdenas; David O Carpenter; Valeria Caso; Ruben Estanislao Castro; Ferrán Catalá-Lopéz; Alanur Cavlin; Xuan Che; Peggy Pei-Chia Chiang; Rajiv Chowdhury; Costas A Christophi; Ting-Wu Chuang; Massimo Cirillo; Iuri da Costa Leite; Karen J Courville; Lalit Dandona; Rakhi Dandona; Adrian Davis; Anand Dayama; Kebede Deribe; Samath D Dharmaratne; Mukesh K Dherani; Uğur Dilmen; Eric L Ding; Karen M Edmond; Sergei Petrovich Ermakov; Farshad Farzadfar; Seyed-Mohammad Fereshtehnejad; Daniel Obadare Fijabi; Nataliya Foigt; Mohammad H Forouzanfar; Ana C Garcia; Johanna M Geleijnse; Bradford D Gessner; Ketevan Goginashvili; Philimon Gona; Atsushi Goto; Hebe N Gouda; Mark A Green; Karen Fern Greenwell; Harish Chander Gugnani; Rahul Gupta; Randah Ribhi Hamadeh; Mouhanad Hammami; Hilda L Harb; Simon Hay; Mohammad T Hedayati; H Dean Hosgood; Damian G Hoy; Bulat T Idrisov; Farhad Islami; Samaya Ismayilova; Vivekanand Jha; Guohong Jiang; Jost B Jonas; Knud Juel; Edmond Kato Kabagambe; Dhruv S Kazi; Andre Pascal Kengne; Maia Kereselidze; Yousef Saleh Khader; Shams Eldin Ali Hassan Khalifa; Young-Ho Khang; Daniel Kim; Yohannes Kinfu; Jonas M Kinge; Yoshihiro Kokubo; Soewarta Kosen; Barthelemy Kuate Defo; G Anil Kumar; Kaushalendra Kumar; Ravi B Kumar; Taavi Lai; Qing Lan; Anders Larsson; Jong-Tae Lee; Mall Leinsalu; Stephen S Lim; Steven E Lipshultz; Giancarlo Logroscino; Paulo A Lotufo; Raimundas Lunevicius; Ronan Anthony Lyons; Stefan Ma; Abbas Ali Mahdi; Melvin Barrientos Marzan; Mohammad Taufiq Mashal; Tasara T Mazorodze; John J McGrath; Ziad A Memish; Walter Mendoza; George A Mensah; Atte Meretoja; Ted R Miller; Edward J Mills; Karzan Abdulmuhsin Mohammad; Ali H Mokdad; Lorenzo Monasta; Marcella Montico; Ami R Moore; Joanna Moschandreas; William T Msemburi; Ulrich O Mueller; Magdalena M Muszynska; Mohsen Naghavi; Kovin S Naidoo; K M Venkat Narayan; Chakib Nejjari; Marie Ng; Jean de Dieu Ngirabega; Mark J Nieuwenhuijsen; Luke Nyakarahuka; Takayoshi Ohkubo; Saad B Omer; Angel J Paternina Caicedo; Victoria Pillay-van Wyk; Dan Pope; Farshad Pourmalek; Dorairaj Prabhakaran; Sajjad U R Rahman; Saleem M Rana; Robert Quentin Reilly; David Rojas-Rueda; Luca Ronfani; Lesley Rushton; Mohammad Yahya Saeedi; Joshua A Salomon; Uchechukwu Sampson; Itamar S Santos; Monika Sawhney; Jürgen C Schmidt; Marina Shakh-Nazarova; Jun She; Sara Sheikhbahaei; Kenji Shibuya; Hwashin Hyun Shin; Kawkab Shishani; Ivy Shiue; Inga Dora Sigfusdottir; Jasvinder A Singh; Vegard Skirbekk; Karen Sliwa; Sergey S Soshnikov; Luciano A Sposato; Vasiliki Kalliopi Stathopoulou; Konstantinos Stroumpoulis; Karen M Tabb; Roberto Tchio Talongwa; Carolina Maria Teixeira; Abdullah Sulieman Terkawi; Alan J Thomson; Andrew L Thorne-Lyman; Hideaki Toyoshima; Zacharie Tsala Dimbuene; Parfait Uwaliraye; Selen Begüm Uzun; Tommi J Vasankari; Ana Maria Nogales Vasconcelos; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Stephen Waller; Xia Wan; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Ronny Westerman; James D Wilkinson; Hywel C Williams; Yang C Yang; Gokalp Kadri Yentur; Paul Yip; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Kim Yun Jin; Maysaa El Sayed Zaki; Shankuan Zhu; Theo Vos; Alan D Lopez; Christopher J L Murray
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

8.  The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.

Authors:  Lin Ruan; Guan-Yu Chen; Zhen Liu; Yun Zhao; Guang-Yu Xu; Shu-Fang Li; Chun-Ni Li; Lin-Shan Chen; Zheng Tao
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

9.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 10.  Platelets and Multi-Organ Failure in Sepsis.

Authors:  Elisabetta Greco; Enrico Lupia; Ornella Bosco; Barbara Vizio; Giuseppe Montrucchio
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

View more
  3 in total

1.  Identification of novel biomarkers for sepsis diagnosis via serum proteomic analysis using iTRAQ-2D-LC-MS/MS.

Authors:  Meng Li; Rongrong Ren; Molei Yan; Shangzhong Chen; Chen Chen; Jing Yan
Journal:  J Clin Lab Anal       Date:  2021-11-26       Impact factor: 2.352

2.  C-Reactive Protein-to-Albumin Ratio as an Early Biomarker to Identify Sepsis in Neonates with Pneumonia.

Authors:  Ping Kang; Wen Kang; Yi Li; Tiewei Li
Journal:  Mediators Inflamm       Date:  2022-07-14       Impact factor: 4.529

3.  Prognostic value of platelet count-related ratios on admission in patients with pyogenic liver abscess.

Authors:  Shixiao Li; Sufei Yu; Jiajia Qin; Minfei Peng; Jiao Qian; Peng Zhou
Journal:  BMC Infect Dis       Date:  2022-07-21       Impact factor: 3.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.